Neurochemical markers as potential indicators of postmortem tissue quality.

Journal: Handbook of clinical neurology

Volume: 150

Issue: 

Year of Publication: 2018

Affiliated Institutions:  Department of Medical Physiology, University of Nairobi, Kenya. Department of Neuropathology, Institute of Pathology, University of Würzburg, Germany. Department of Child and Adolescent Psychiatry and Psychotherapy, University Hospital of Psychiatry Zurich, University of Zurich, Switzerland; Center for Mental Health, Department of Psychiatry, Psychosomatics and Psychotherapy, University Hospital Würzburg, Würzburg, Germany; Neuroscience Center Zurich and Zurich; Center for Integrative Human Physiology, University of Zurich, Switzerland. Center for Mental Health, Department of Psychiatry, Psychosomatics and Psychotherapy, University Hospital Würzburg, Würzburg, Germany. Electronic address: peter.riederer@uni-wuerzburg.de.

Abstract summary 

Premortem, postmortem, and storage conditions are parameters that can influence the quality and interpretation of data from studies of postmortem tissue. While many neurochemicals in the brain are relatively stable for several hours after death if stored at 4°C, the postmortem delay nevertheless becomes an important variable when examining the disease state because neurochemical levels may change with extended postmortem delay. Moreover, in the postmortem brain, neurochemical levels may also play a key role in determining the diagnosis. This is particularly true for some neurodegenerative disorders where many of the clinical features of the disease are not exclusive to one illness. It is therefore imperative to employ brain tissue of the highest quality from both nondiseased (control) and diseased brain tissue to ascertain the specific molecular and genetic mechanisms particular to the disease pathogenesis. Consequently, it would be very useful if specific markers could be employed to demonstrate and determine the quality of postmortem brain tissue that is suitable for such studies. In this chapter, the following neurochemical markers are critically reviewed as potential candidates to assess the quality of postmortem brain tissue: tryptophan levels, glutathione levels (and glutathione metabolic enzymes), enzymatic activities (glutamate decarboxylase, phosphofructokinase-1), epigenetic enzymes (acetyltransferase, methyltransferase), and tissue pH. In conclusion, the neurochemical tryptophan appears to be the most suitable candidate for assessing the integrity and quality of postmortem brain tissue. However, to optimize the quality of the samples, neuropathologic diagnostic characterization must also be employed in the interpretation and understanding of the data generated. It would also be judicious to consider as many premortem and postmortem conditions as possible as they can also affect the genetic and molecular integrity of the brain tissue.

Authors & Co-authors:  Sian-Hülsmann Monoranu Grünblatt Riederer

Study Outcome 

Source Link: Visit source

Statistics
Citations : 
Authors :  4
Identifiers
Doi : 10.1016/B978-0-444-63639-3.00009-8
SSN : 0072-9752
Study Population
Male,Female
Mesh Terms
Biomarkers
Other Terms
agonal state;brain;glutamate decarboxylase (GAD);pH and quality;phosphofructokinase-1 (PFK);postmortem interval;tryptophan
Study Design
Study Approach
Country of Study
Kenya
Publication Country
Netherlands